Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.

Michel MandroJoseph Nelson Fodjo SieweDeby MukendiAlfred DusabimanaSonia MenonSteven HaesendonckxRichard LokondaSwabra NakatoFrancoise NyisiGermain AbhafuleDeogratias Wonya'RossiJean Marie JakwongPatrick SuykerbuykJacques MeganckAn HotterbeekxRobert Colebunders

Published in: PLoS neglected tropical diseases (2020)

Registration: www.clinicaltrials.gov; NCT03052998.

Keyphrases

clinical trial
early stage
open label
phase ii
study protocol
combination therapy
double blind
replacement therapy
drug administration